New NIH Grant: 2026 Nasopharyngeal Carcinoma Gordon Research Conference — $15K at Unknown Institution
WHY IT MATTERS
This conference will bring together leading NPC researchers to advance understanding of why this cancer develops earlier in life and disproportionately affects certain populations, potentially leading to better screening and treatment options for affected patients.
The National Institutes of Health is funding a scientific conference in May 2026 focused on nasopharyngeal carcinoma (NPC), a rare cancer that starts in the back of the nose and throat. This cancer is particularly common in certain regions like Alaska and affects people in their 40s, much earlier than most other cancers. Researchers will gather to discuss how genetics, viruses, and other factors cause this disease and how to treat it better.
Project: 2026 Nasopharyngeal Carcinoma Gordon Research Conference PI: GEWURZ, BENJAMIN ELISON Institution: Unknown Institution Funding: $15K Start Date: 2026-05-09 Abstract: PROJECT SUMMARY/ABSTRACT This conference grant application requests funds to help support the Gordon Research Conference (GRC) on Nasopharyngeal carcinoma (NPC) May 10 - 15, 2026. NPC is a deadly cancer arising in the nasopharynx which has high incidence in particular regions, including Alaska. The peak age at NPC diagnosis is in the mid-forties, which is two decades earlier than for many other common cancers. Thus, NPC has a significant socioeconomic impact globally. The etiology of this unique cancer includes three significant co-factors: host genetics, Epstein- Barr Virus (EBV) infection, a